Experience with ceftazidime-avibactam treatment in a tertiary care center in Saudi Arabia.
J Infect Public Health
; 11(6): 793-795, 2018.
Article
em En
| MEDLINE
| ID: mdl-29706317
ABSTRACT
INTRODUCTION:
Carbapenem-resistant organisms have become major healthcare-associated pathogens and are responsible for significant morbidity and mortality worldwide. CASES AND MANAGEMENTS This case-series describes our experience with ceftazidime-avibactam in the treatment of six cases with carbapenem-resistant organisms in King Abdulaziz Medical City in Riyadh, Saudi Arabia. After trying various combinations of antibiotic therapies without improvement, cases were treated with ceftazidime-avibactam.OUTCOMES:
Five of the six achieved complete cure, both clinically and microbiologically.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Ceftazidima
/
Infecções por Bactérias Gram-Negativas
/
Compostos Azabicíclicos
/
Inibidores de beta-Lactamases
/
Antibacterianos
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article